Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $8.17B.
ENTERPRISE VALUE (EV)
$8.17B
Caris Life Sciences, Inc.
Market Cap
$8.59B
Enterprise Value (EV)
$8.17B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Caris Life Sciences, Inc. (CAI) | $8.59B | $8.17B |
| Oscar Health, Inc. (OSCR)vs › | $8.41B | $4.76B |
| Arrowhead Pharmaceuticals, Inc. (ARWR)vs › | $8.78B | $9.59B |
| Axsome Therapeutics, Inc. (AXSM)vs › | $9.11B | $9.01B |
| Bruker Corporation (BRKRP)vs › | $9.35B | $11.08B |
| Cytokinetics, Incorporated (CYTK)vs › | $7.80B | $8.82B |
| Insulet Corp. (PODD)vs › | $9.39B | $9.81B |
| HealthEquity, Inc. (HQY)vs › | $7.65B | $8.37B |
| Hinge Health, Inc. (HNGE)vs › | $7.61B | $7.33B |
| Henry Schein, Inc. (HSIC)vs › | $9.60B | $13.25B |
Market Cap
$8.59B
Total Debt
$378.99M
Cash
$797.80M
Enterprise Value
$8.17B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
